A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Nov 5, 2012

Keywords

ClinConnect Summary

There will be 6 months of follow up including 3 medical visits for each patients:

* M0 (medical visit for inclusion)
* follow up between M0 - M3
* M3 (medical visit at 3 months after inclusion)
* follow up between M3 - M6
* M6 (medical visit at 6 months after inclusion)

At the inclusion visit (M0), after the verification of inclusion and non-inclusion criteria, the following information will be collected:

* Socio-demographical data : age, sex, level of education (primary, secondary, college, university), occupational category (INSEE in 6 categories)
* Items of the ACR 1987 and ACR/EULAR ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years;
• • Having Rheumatoid Arthritis (RA) since more than 6 months, meeting the ACR 1987 and the ACR / EULAR 2010;
• * Treatment of RA:
• • Treatment of disease modifying anti-rheumatic drugs (DRMADs) or biological treatment stable for more than 2 months;
• • Symptomatic treatment (including corticosteroid) stable for more than 2 months;
• • Receive the medical exam first;
• • Agreed and signed the informed consent form;
• • Ability to comply with the study protocol;
• • Having the social insurance coverage
• Exclusion Criteria:
• • Patients undergoing surgery during the study period;
• • Patients without any affiliation to a social security coverage (or entitled beneficiary);
• • Patients under guardianship or trusteeship.